Kohno H, Taketani S, Tokunaga R
Cell Struct Funct. 1986 Jun;11(2):181-90. doi: 10.1247/csf.11.181.
The treatment of human leukemia K562 cells with 12-0-tetradecanoyl phorbol-13-acetate (TPA) caused a decrease of transferrin receptors. The mechanism of the decrease of the receptors with TPA has been investigated. In cells incubated with TPA, the rate of biosynthesis of transferrin receptors was reduced to 10-20% of that in untreated cells. Pulse-chase experiments showed that turnover of the receptors in TPA-treated cells was accelerated over that in untreated cells. These results indicated that the decrease of transferrin receptors in TPA-treated cells was caused by reduced biosynthesis and accelerated degradation of the receptors.
用12 - O - 十四烷酰佛波醇 - 13 - 乙酸酯(TPA)处理人白血病K562细胞会导致转铁蛋白受体减少。已对TPA导致受体减少的机制进行了研究。在用TPA孵育的细胞中,转铁蛋白受体的生物合成速率降至未处理细胞的10% - 20%。脉冲追踪实验表明,TPA处理的细胞中受体的周转比未处理细胞加快。这些结果表明,TPA处理细胞中转铁蛋白受体的减少是由于受体生物合成减少和降解加速所致。